In his final thoughts, Dr Gerds discusses emerging therapies for the treatment of PV.
Polycythemia Vera Guideline Updates 2023 | videos
Uncontrolled PV is highlighted by a key opinion leader.
Dr Gerds explores the pros and cons of the present treatment approach for PV.
Dr Gerds provides insight regarding the evaluation of dosing and effectiveness in PV treatment.
Dr Gerds navigates frontline treatments for patients diagnosed with PV.
Dr Gerds reviews the process for updating NCCN guidelines surrounding PV treatment.
Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.
Dr Gerds explores similarities and differences in symptomatic patients compared to asymptomatic patients with PV.
Risk factors for developing polycythemia vera (PV) are discussed by Aaron Gerds, MD, MS.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
3
AI Phenotyping Links Cardiovascular, Kidney Disease to Rapid MASH Progression, Higher Costs
4
Clinical Trials Leave Many ALL Patients Behind: Emily K. Curran, MD
5